FDA approves new DNA-based test to determine blood compatibi
The U.S. Food and Drug Administration has approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types.

ID CORE XT is the second molecular assay approved for use in transfusion medicine, and the first to report genotypes as final results.

A study was conducted to compare the typing results of the ID CORE XT Test with licensed serological reagents, the first FDA-approved molecular assay, and DNA sequencing tests. The results demonstrated comparable performance between the methods.

Read more here: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm623195.htm
S●●●●a K●●●●●a and 1 others like this1 share
Like
Comment
Share